
Airbus announced FY2025 results, delivering 793 commercial jets and generating €73.4 billion in revenue, a 6% year‑on‑year increase. Adjusted EBIT rose 33% to €7.1 billion, while net income grew 23% to €5.2 billion and EPS to €6.61. The order backlog hit a record 8,754 aircraft and total order intake climbed 19% to €123.3 billion. Airbus proposed a €3.20 per‑share dividend and set 2026 guidance for 870 deliveries and €7.5 billion adjusted EBIT.
Novo Nordisk’s shares have slumped 66% from their 2024 peak, reflecting weak 2026 guidance and fierce competition from Eli Lilly in the GLP‑1 arena. The Danish firm recently introduced the first oral GLP‑1 pill, positioning it ahead of Lilly’s upcoming tablet and...
Centrica reported a 41% plunge in 2025 earnings per share to GBX 11, matching FactSet consensus. After completing a £2 billion share‑buyback programme, the company announced a pause to the scheme. Soft 2026 guidance, driven by weaker gas and power trading, pushed...
BAE Systems posted an 8% revenue rise and a 9% jump in operating profit for 2025, expanding its order book by £2.7 bn versus 2024. The company lifted its dividend 10% to 36p per share, while its stock surged 23% year‑to‑date,...
Pernod Ricard reported a first‑half sales decline across all five priority markets, with profits pressured by foreign‑exchange volatility and higher costs. The second quarter showed a modest rebound, helped by stronger demand in India and duty‑free channels. The group reaffirmed its...

The Norwegian Group posted a record operating profit of NOK 3.732 billion for 2025, the highest in its history, and a NOK 21 million EBIT in Q4 after a loss the previous year. Passenger traffic rose to 27.3 million for the full year, with Norwegian’s...
The Bocconi Institute proposes six pragmatic reforms to close Europe’s “scale‑up gap” and boost venture‑capital financing for innovative firms. Using Dealroom data on 64,500 EU start‑ups, the report shows that VC investment in scale‑ups is under 10% of U.S. levels...
Nanobiotix SA filed a regulatory disclosure on February 17 2026 detailing its capital structure as of January 31 2026. The company reported 48,450,358 shares outstanding, with a total of 50,153,460 theoretical voting rights and 50,131,342 exercisable voting rights. The filing complies with French Commercial...
Pelagic Credit Plc issued an update on its planned private placement and intended listing on Euronext Growth Oslo. The company reports strong investor interest and is revisiting the offering’s structure, which could diverge from the February 9 outline. Size, timing and...
On 17 February 2026 Nordea Bank Abp completed a share repurchase of 404,487 shares at a weighted average price of €16.47, costing €6.66 million. The buy‑back was executed across the Helsinki, Stockholm and Copenhagen exchanges and forms part of a €500 million...

Genmab A/S announced a share buy‑back program to repurchase up to 342,130 ordinary shares, representing a maximum spend of 725 million Danish kroner. The program, designed to fulfill obligations under its Restricted Stock Unit plan, will run from February 18 to March 31 2026...
Coca‑Cola Europacific Partners reported 2025 results with 2.3% revenue growth, 2.7% volume increase and a 5.4% rise in operating profit, driven by pricing power and efficiency initiatives despite headwinds in Germany and Indonesia. The firm’s profitability outperformed forecasts, prompting Morningstar to...

Apax Partners pulled its £575 million takeover bid for FTSE 250 software firm Pinewood on February 16, citing challenging market conditions. The withdrawal triggered an immediate 31% drop in Pinewood’s share price, the steepest decline in weeks. Analysts view the move as a...
Leading European large‑cap equity funds rebalanced portfolios in December, increasing exposure to financial services, healthcare and, to a lesser extent, industrials. At the same time, allocations to basic materials, consumer defensive and technology stocks were trimmed. ASML emerged as the...
Vicat reported FY 2025 organic sales up 3.3% year‑on‑year, accelerated to 8.1% in Q4, while EBITDA rose 3.7% LFL to €771 million with a stable 20% margin. Net debt fell €85 million, bringing leverage to 1.49 times, and free cash flow remained strong at...